PT1951274E - Parapoxvírus em combinação com agentes quimioterapêuticos citotóxicos clássicos como bioquimioterapia para o tratamento de cancro - Google Patents
Parapoxvírus em combinação com agentes quimioterapêuticos citotóxicos clássicos como bioquimioterapia para o tratamento de cancro Download PDFInfo
- Publication number
- PT1951274E PT1951274E PT06806214T PT06806214T PT1951274E PT 1951274 E PT1951274 E PT 1951274E PT 06806214 T PT06806214 T PT 06806214T PT 06806214 T PT06806214 T PT 06806214T PT 1951274 E PT1951274 E PT 1951274E
- Authority
- PT
- Portugal
- Prior art keywords
- parapoxviruses
- biochemotherapy
- cancer
- treatment
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05025600 | 2005-11-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1951274E true PT1951274E (pt) | 2009-12-14 |
Family
ID=37654955
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT06806214T PT1951274E (pt) | 2005-11-24 | 2006-10-12 | Parapoxvírus em combinação com agentes quimioterapêuticos citotóxicos clássicos como bioquimioterapia para o tratamento de cancro |
Country Status (15)
Country | Link |
---|---|
US (1) | US7897159B2 (pl) |
EP (1) | EP1951274B1 (pl) |
JP (1) | JP5164849B2 (pl) |
CN (1) | CN101312737B (pl) |
AR (1) | AR057922A1 (pl) |
AT (1) | ATE450266T1 (pl) |
CA (1) | CA2630833C (pl) |
DE (1) | DE602006010902D1 (pl) |
DK (1) | DK1951274T3 (pl) |
ES (1) | ES2335308T3 (pl) |
HK (1) | HK1117427A1 (pl) |
PL (1) | PL1951274T3 (pl) |
PT (1) | PT1951274E (pl) |
TW (1) | TWI415617B (pl) |
WO (1) | WO2007059821A1 (pl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102886045A (zh) | 2005-02-03 | 2013-01-23 | 综合医院公司 | 治疗吉非替尼耐药性癌症的方法 |
KR101354828B1 (ko) | 2005-11-04 | 2014-02-18 | 와이어쓰 엘엘씨 | mTOR 저해자, 헤르셉틴, 및/또는 HKI-272의항신생물성 조합 |
US8022216B2 (en) | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
EP3135285B1 (en) | 2008-06-17 | 2018-08-15 | Wyeth LLC | Antineoplastic combinations containing hki-272 and vinorelbine |
EP2326329B1 (en) | 2008-08-04 | 2017-01-11 | Wyeth LLC | Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine |
DK3000467T3 (da) | 2009-04-06 | 2023-03-27 | Wyeth Llc | Behandling med neratinib mod brystkræft |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3816139A1 (de) | 1987-10-17 | 1989-04-27 | Bayer Ag | Verfahren zur herstellung von paramunitaetsinducern |
DE19922407A1 (de) * | 1999-05-14 | 2000-11-16 | Bayer Ag | Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus |
AU2001270631B2 (en) * | 2000-07-11 | 2005-07-07 | Bayer Aktiengesellschaft | Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
AR035227A1 (es) * | 2001-02-20 | 2004-05-05 | Oncolytics Biotech Inc | Uso de un agente quimioterapeutico para la manufactura de un medicamento para la sensibilizacion de celulas neoplasicas resistentes a agentes quimioterapeuticos con reovirus |
NZ512341A (en) * | 2001-06-13 | 2004-02-27 | Bayer Ag | Polynucleotides between 15 and 100 base pairs in length coding for parapoxvirus ovis (PPVO)/vaccinia virus recombinant (VVOV) viral genome fragments |
EP2269619A1 (en) * | 2002-08-12 | 2011-01-05 | Jennerex Biotherapeutics ULC | Methods and compositions concerning poxviruses and cancer |
-
2006
- 2006-10-12 DE DE602006010902T patent/DE602006010902D1/de active Active
- 2006-10-12 CA CA2630833A patent/CA2630833C/en active Active
- 2006-10-12 CN CN2006800439506A patent/CN101312737B/zh active Active
- 2006-10-12 PT PT06806214T patent/PT1951274E/pt unknown
- 2006-10-12 JP JP2008541602A patent/JP5164849B2/ja active Active
- 2006-10-12 DK DK06806214.0T patent/DK1951274T3/da active
- 2006-10-12 ES ES06806214T patent/ES2335308T3/es active Active
- 2006-10-12 AT AT06806214T patent/ATE450266T1/de active
- 2006-10-12 EP EP06806214A patent/EP1951274B1/en active Active
- 2006-10-12 WO PCT/EP2006/009855 patent/WO2007059821A1/en active Application Filing
- 2006-10-12 PL PL06806214T patent/PL1951274T3/pl unknown
- 2006-11-23 TW TW095143295A patent/TWI415617B/zh active
- 2006-11-23 AR ARP060105172A patent/AR057922A1/es not_active Application Discontinuation
-
2008
- 2008-05-19 US US12/123,360 patent/US7897159B2/en active Active
- 2008-11-10 HK HK08112329.9A patent/HK1117427A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE602006010902D1 (de) | 2010-01-14 |
US20090035269A1 (en) | 2009-02-05 |
ES2335308T3 (es) | 2010-03-24 |
CA2630833C (en) | 2015-01-06 |
DK1951274T3 (da) | 2010-02-01 |
AR057922A1 (es) | 2007-12-26 |
WO2007059821A1 (en) | 2007-05-31 |
PL1951274T3 (pl) | 2010-05-31 |
EP1951274B1 (en) | 2009-12-02 |
TW200738250A (en) | 2007-10-16 |
EP1951274A1 (en) | 2008-08-06 |
CN101312737A (zh) | 2008-11-26 |
JP2009517347A (ja) | 2009-04-30 |
JP5164849B2 (ja) | 2013-03-21 |
CA2630833A1 (en) | 2007-05-31 |
HK1117427A1 (en) | 2009-01-16 |
TWI415617B (zh) | 2013-11-21 |
ATE450266T1 (de) | 2009-12-15 |
US7897159B2 (en) | 2011-03-01 |
CN101312737B (zh) | 2012-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1700015I1 (hu) | PDGFR-alfa elleni antitest és alkalmazása tumorok kezelésénél | |
IL186662A0 (en) | Combination cancer therapy with | |
HUE059861T2 (hu) | N-Szubsztituált 2,5-dioxo-azolin vegyületek a rák kezelésében való felhasználásra | |
IL191832A0 (en) | Pyridiazinone derivatives for the treatment of tumours | |
IL201211A (en) | K3 ip-alpha quinoxaline inhibitors for use in combination with chemotherapeutic agents for use in the treatment of cancer | |
EP1940456A4 (en) | WWOX GENE, VECTORS COMPRISING THE SAME, AND USES THEREOF IN THE TREATMENT OF CANCER | |
SI2358697T1 (sl) | Spojine izoindolina za uporabo pri zdravljenju raka | |
HK1215683A1 (zh) | 抗葉酸藥在癌症治療中的聯合應用 | |
PT2101731T (pt) | Endoxifeno para utilização no tratamento de cancro | |
EP1868435A4 (en) | COMBINATIONS, METHODS AND COMPOSITIONS FOR TREATING CANCER | |
IL178261A0 (en) | Use of 5,10-methylene tetrahydrofolate for the treatment of cancer | |
PL2564872T3 (pl) | Mazindol sam lub w kombinacji z żelazem do leczenia deficytu uwagi/nadpobudliwości | |
HK1117427A1 (en) | Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer | |
AU2006251169A8 (en) | Tetrahydropyridothiophenes for use in the treatment of cancer | |
AU2006251167A8 (en) | Tetrahydropyridothiophenes for use in the treatment of cancer | |
EP1891047A4 (en) | A 1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID SUITABLE FOR THE CHEMOTHERAPY OF CANCER | |
EP1952811A4 (en) | USE OF ERIOCALYXIN B FOR THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF LEUKEMIA | |
GB0517387D0 (en) | Combinations for the treatment of cancer | |
IL206189A0 (en) | Compound for use in the treatment of cancer | |
ZA200709542B (en) | Combination therapy in the treatment of cancer | |
AU307436S (en) | Angle grinder | |
AU303295S (en) | Belt | |
IL187792A0 (en) | 4-anilino-3-quinolinecarbonitriles for the treatment of cancer | |
EP1917041A4 (en) | USE OF FRUCTOSE-BASED THERAPIES FOR CANCER TREATMENT | |
IL185518A0 (en) | 1,3-thiazole-5-carboxamides useful as cancer chemotherapeutic agents |